Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Rice, MD Anderson researchers refine technique for attacking hard-to-reach tumors

Short, customized carbon nanotubes have the potential to deliver drugs to pancreatic cancer cells and destroy them from within, according to researchers at Rice University and the University of Texas MD Anderson Cancer Center.

6 Jun 2014

SYNERA can help prevent needle stick pain associated with superficial IVs

Galen US Incorporated today announced that the U.S. Food and Drug Administration (FDA) recently approved a labeling change that allows SYNERA® (lidocaine and tetracaine) topical patch to be used at home.

4 Jun 2014

Squatty Potty toilet stool improves severity of constipation symptoms

When used as a treatment, the original Squatty Potty (www.squattypotty.com) toilet stool significantly improves the severity of constipation symptoms within one month of use among 84 percent of the participants of a recently released scientific study.

4 Jun 2014

Researchers find way to prevent nonalcoholic fatty liver disease

Studying mice, researchers have found a way to prevent nonalcoholic fatty liver disease, the most common cause of chronic liver disease worldwide.

4 Jun 2014

$Vitamin D with calcium can protect against risk of common bone fractures for seniors$

Vitamin D with calcium can protect against risk of common bone fractures for seniors

For seniors over the age of 65, taking a daily supplement of vitamin D with calcium—but not vitamin D alone—can offer some protection against the risk of common bone fractures, according to an updated review from The Cochrane Library.

4 Jun 2014

EHR solutions provider, ChartLogic, partners with Kareo

ChartLogic, a leader in electronic health record solutions for specialty and primary care physician practices, today announced a partnership with billing solutions powerhouse, Kareo, that will allow the company to offer its clients best-of-breed revenue cycle management.

2 Jun 2014

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.

31 May 2014

American College of Gastroenterology develops new podcast for World Digestive Health Day

For World Digestive Health Day, the American College of Gastroenterology, along with World Gastroenterology Organisation (WGO), observes the 2014 focus on the human gut microbiome and its impact on health and disease. Scientific understanding of the gut microbiome - the diverse and complex microbial community that resides in the intestine - has rapidly evolved in recent years.

31 May 2014

Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Actavis plc today announced that it has entered into an agreement with Cephalon, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Nuvigil® (armodafinil tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg).

31 May 2014

Biomedical scientists explore mechanisms of novel treatments for HCV

As new treatments for hepatitis C virus (HCV) are approved, biomedical scientists are exploring their mechanisms and what they reveal about the virus.

29 May 2014

Study: Individuals' diet influences gut microbial diversity

Scientists from The University of Texas at Austin and five other institutions have discovered that the more diverse the diet of a fish, the less diverse are the microbes living in its gut. If the effect is confirmed in humans, it could mean that the combinations of foods people eat can influence the diversity of their gut microbes.

29 May 2014

EC approves Takeda's Entyvio for treatment of adults with ulcerative colitis, Crohn’s disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn’s disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.

28 May 2014

Biologists show bioelectrical signals control tumors arising from cancer-causing genes, fatty acid

Developmental biologists at Tufts University, using a tadpole model, have shown that bioelectrical signals from distant cells control the incidence of tumors arising from cancer-causing genes and that this process is impacted by levels of a common fatty acid produced by bacteria found in the tadpole and also in humans.

28 May 2014

Eliminating scar tissue, inflammation may make tumors more deadly, find researchers

New research represents a significant change in the understanding of how pancreatic cancer grows - and how it might be defeated.

23 May 2014

Gastroenterologists select efficacy over safety, tolerability when prescribing new drug for Crohn's disease

Decision Resources Group finds that, when asked to indicate the relative importance of product attributes when prescribing a new drug for Crohn's disease (CD), the highest percentages of surveyed gastroenterologists in the United States and Europe selected efficacy over safety and tolerability or delivery.

22 May 2014

Effects of radiofrequency ablation and complete endoscopic resection are equal in dysplastic Barrett's esophagus

According to a new systematic review article, radiofrequency ablation and complete endoscopic resection are equally effective in the short-term treatment of dysplastic Barrett's esophagus, but adverse event rates are higher with complete endoscopic resection.

22 May 2014

Cell Science Systems launches new blood test profile for GI disorders

Distinguishing the cause of gut disorders can be complicated. Therefore, Cell Science Systems, Corp. today announced the launch of a new test to help clinicians reach a diagnosis; and, suggest dietary strategies to improve whatever gut malady a person may have.

21 May 2014

69% of healthy American adults are infected with 109 strains of human papillomavirus

In what is believed to be the largest and most detailed genetic analysis of its kind, researchers at NYU Langone Medical Center and elsewhere have concluded that 69 percent of healthy American adults are infected with one or more of 109 strains of human papillomavirus (HPV).

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Ferring launches new interactive website Guts4life for people with IBD

Ferring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (www.guts4life.com), a new interactive website with information, support and inspiration for people concerned with Crohn's disease and ulcerative colitis, conditions known as inflammatory bowel diseases (IBD).

19 May 2014

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Rice, MD Anderson researchers refine technique for attacking hard-to-reach tumors

SYNERA can help prevent needle stick pain associated with superficial IVs

Squatty Potty toilet stool improves severity of constipation symptoms

Researchers find way to prevent nonalcoholic fatty liver disease

Vitamin D with calcium can protect against risk of common bone fractures for seniors

EHR solutions provider, ChartLogic, partners with Kareo

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

American College of Gastroenterology develops new podcast for World Digestive Health Day

Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Biomedical scientists explore mechanisms of novel treatments for HCV

Study: Individuals' diet influences gut microbial diversity

EC approves Takeda's Entyvio for treatment of adults with ulcerative colitis, Crohn’s disease

Biologists show bioelectrical signals control tumors arising from cancer-causing genes, fatty acid

Eliminating scar tissue, inflammation may make tumors more deadly, find researchers

Gastroenterologists select efficacy over safety, tolerability when prescribing new drug for Crohn's disease

Effects of radiofrequency ablation and complete endoscopic resection are equal in dysplastic Barrett's esophagus

Cell Science Systems launches new blood test profile for GI disorders

69% of healthy American adults are infected with 109 strains of human papillomavirus

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Ferring launches new interactive website Guts4life for people with IBD

Microbiology eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Microbiology eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in